Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Debt Ratio (2024 - 2026)

Updated

Radiopharm Theranostics' (RADX) Debt Ratio was 0.43 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 15.5% from 0.37 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Debt Ratio (2024 - 2026) Analysis & Trends

Dating back to fiscal Q4 2024, Radiopharm Theranostics' Debt Ratio record includes 4 quarters.

  • By fiscal year, Debt Ratio came in at 0.37 in FY2025 and 0.00 in FY2024.
  • The fiscal Q4 2026 figure ranks as the highest quarterly Debt Ratio since fiscal Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 0.33
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 0.23
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 0.55
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 0.41
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -0.10
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 0.56
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 0.51
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 0.31
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - 0.11
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11
Jun 30, 2025 0.04
Dec 31, 2024 0.02
Jun 30, 2024 0.09
API Access

Radiopharm Theranostics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RADX&period=max&api_key=YOUR_API_KEY